Deciphering the mechanisms that regulate TDP-43 cytoplasmic/nuclear levels is critical to defining therapeutic strategies since the presence of TDP-43 in cytoplasmic inclusions with less TDP-43 in the nucleus is a pathological hallmark of ALS and FTLD2. Here, TARDBP is linked to amyotrophic lateral sclerosis.